Friday, 20 November 2026European Markets

HOFSETH BIOCARE Stock Impressive Fall 13% So Far On Monday, Underperforms Market

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

On Monday, Norwegian health ingredient supplier HOFSETH BIOCARE witnessed a sharp drop in its shares on the Oslo Bors Benchmark Index_GI. Contrasting their four consecutive sessions of gains on this exchange, the shares fell by 13.37% closing at Kr2.98. This is notably lower than the company's last session at kr3.44, which was 12.91% lower than its 52-week high of kr3.95.

Performance Despite Health Product Offerings

Despite offering a wide range of health products, including salmon oil for maintaining healthy cholesterol levels and joint health, and marine calcium powder to support bone strength, HOFSETH BIOCARE's financial performance leaves much to be desired. Over the trailing twelve months, the company reported negative earnings per share of kr-0.41 and a return on equity of -126.49%, indicating a significant reduction in profitability. Additionally, the company also exhibited negative EBITDA earnings (Earnings Before Interest Tax Depreciation Amortization).

OverSelling Situation

The stochastic oscillator, an indicator classifying the company's current stock market position, denotes the company as being oversold. Based on a wide range of indicators detecting overbought and oversold conditions, an oversold status often suggests undervaluation. This might present potential investors with an opportunity to purchase securities at lower prices. Regardless, prospective buyers must judiciously evaluate both the financial health of the company and broader market trends before deciding on their investment.

More news about HOFSETH BIOCARE (HBC.OL).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 24 Jul 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›